Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
¿£ºê·¼ÁÖ»ç25mg - »õâ
|
Çѱ¹¿ÍÀ̾ |
E35400331 | Etanercept | Àü¹®ÀǾàǰ | ±Þ¿© |
| etanercept |
a genetically engineered anti-TNF compound (trade name Enbrel) consisting of receptors that bind TNF; it is injected twice a week in the treatment of rheumatoid arthritis
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| etanercept |
Etanercept (Enbrel®, co-marketed by Amgen and Wyeth) is a recombinant human soluble tumor necrosis factor-alpha (TNFα) receptor. It is a small protein (p75, i.e., its molecular weight is 75 kDa) that binds TNFα and decreases its role in inflammatory diseases such as rheumatoid arthritis, Crohn's disease, psoriasis, psoriatic arthritis, and ankylosing spondylitis. ...
Ãâó: en.wikipedia.org/wiki/Etanercept
|
| Etanercept | a genetically engineered anti-TNF compound (trade name Enbrel) consisting of receptors that bind TNF |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|